Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation (RELACS): An International Multicenter, Randomized Controlled, Two-arm, Assessor-blinded, Trial

NCT06696079 is registered in ClinicalTrials.gov with Rahul Raj as lead sponsor.

NCT NCT06696079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06696079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation (RELACS): An International Multicenter, Randomized Controlled, Two-arm, Assessor-blinded, Trial
Lead sponsor
Rahul Raj
Phase
Not applicable
Overall status
Recruiting
Start date
July 7, 2025
Completion date
June 30, 2027
Enrollment
332 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), chronic subdural hematoma